Factors affecting nosocomial death in elderly patients with COVID-19 and construction of a risk predictive model
DAI Jingrong1, XIAO Bao2, LI Lin2, HU Jiangying2, LIU Bin2*
1. Department of General Medicine;2. Department of Emergency, the Affiliated Changsha Hospital of Xiangya School of Medical, Central South University/the First Hospital of Changsha, Changsha 410005, China
DAI Jingrong, XIAO Bao, LI Lin, HU Jiangying, LIU Bin. Factors affecting nosocomial death in elderly patients with COVID-19 and construction of a risk predictive model[J]. Basic & Clinical Medicine, 2024, 44(1): 92-97.
Smati S, Tramunt B, Wargny M,et al. COVID-19 and diabetes outcomes: rationale for and updates from the CORONADO study[J]. Curr Diab Rep,2022,22:53-63.
[5]
Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes[J]. Metabolism, 2020,107:154217. doi:10.1016/j.metabol.2020.154217
[6]
Jayakrishnan B, Nair P. COVID-19, obstructive airway disease and eosinophils: a complex interplay[J]. Sultan Qaboos Univ Med J, 2022,22:163-166.
[7]
Nugroho J, Wardhana A, Mulia EP, et al. Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: a Meta-analysis[J]. Clin Hemorheol Microcirc, 2021,77:221-231.
Kuang ZS, Yang YL, Wei W, et al. Clinical charac-teristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompro-mised host: a retrospective observational study[J]. World J Emerg Med,2020,11:145-151.
[10]
Gupta GS. The Lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients[J].Inflammation,2022,45:2091-2123.